Cited by

• Mycobacterium.

  Barksdale L, Kim KS. Barksdale L, et al. Bacteriol Rev. 1977 Mar;41(1):217-372. doi: 10.1128/br.41.1.217-372.1977. Bacteriol Rev. 1977. PMID: 67839 Free PMC article. Review. No abstract available.
• Hydrosoluble immunostimulants of bacterial and synthetic origins.

  Jollès P. Jollès P. Experientia. 1976 Jun 15;32(6):677-83. doi: 10.1007/BF01919830. Experientia. 1976. PMID: 181265
• Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control study.

  Kodama K, Higashiyama M, Takami K, Oda K, Okami J, Maeda J, Akazawa T, Matsumoto M, Seya T, Wada M, Toyoshima K. Kodama K, et al. Surg Today. 2009;39(3):194-200. doi: 10.1007/s00595-008-3826-3. Epub 2009 Mar 12. Surg Today. 2009. PMID: 19280277
• Cell wall of Mycobacterium lepraemurium strain Hawaii.

  Azuma I, Yamamura Y, Tanaka Y, Kosaka K, Mori T. Azuma I, et al. J Bacteriol. 1973 Jan;113(1):515-8. doi: 10.1128/jb.113.1.515-518.1973. J Bacteriol. 1973. PMID: 4569700 Free PMC article.
• Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.

  Nishida S, Tsuboi A, Tanemura A, Ito T, Nakajima H, Shirakata T, Morimoto S, Fujiki F, Hosen N, Oji Y, Kumanogoh A, Kawase I, Oka Y, Azuma I, Morita S, Sugiyama H. Nishida S, et al. Medicine (Baltimore). 2019 Aug;98(33):e16771. doi: 10.1097/MD.0000000000016771. Medicine (Baltimore). 2019. PMID: 31415377 Free PMC article. Clinical Trial.